The International Society for Pharmaceutical Engineering (ISPE) has recognized Eli Lilly Kinsale Limited as the Overall ...
The global disposable spinal instrument market is on the brink of remarkable growth, projected to expand from USD 70.4 million in 2024 to USD 141.1 million by 2034, reflecting a robust compound annual ...
According to the latest market research conducted by Future Market Insights (FMI), the global radiotherapy patient positioning accessories market is on the verge of substantial growth over the next ...
The global mucus clearance devices market is poised for significant growth, with sales projected to surpass USD 847.0 million ...
The global multi-parameter patient monitoring market, a cornerstone of modern healthcare technology, is on track for significant expansion over the next decade. Valued at USD 4.8 billion in 2023, the ...
The global retail clinic market is on a trajectory of rapid expansion, with market size projected to rise from an estimated USD 5,659.2 million in 2024 to an impressive USD 12,308.7 million by 2034.
The global tattoo removal laser market is on track for substantial growth, with projections indicating a market value of USD 247.4 million by 2024 and an anticipated Compound Annual Growth Rate (CAGR) ...
The global hematology diagnostic market is on the cusp of a major expansion, projected to soar from USD 780.0 million in 2023 to an astounding USD 2.0 billion by 2033. This remarkable growth ...
The global loop-mediated isothermal amplification market is expected to be valued at USD 110.6 million in 2024. The market is expected to progress at an average rate over the forecast period, with a ...
According to a groundbreaking forecast from Future Market Insights (FMI), the global urology imaging systems market is poised for remarkable growth, with sales expected to surpass USD 486.4 million by ...
Quarterly / Interim StatementDocMorris accelerates Rx growth 15.10.2024 / 06:58 CET/CESTFrauenfeld, 15 October 2024Press releaseDocMorris accelerates Rx growth Rx revenue growth of 12.2 per cent in ...
DENVER, CO / ACCESSWIRE / October 14, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced Josh ...